Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
New drugs targeting weight loss and diabetes management such as Ozempic/Wegovy can help lower the number of young people impacted by type 2 diabetes, a paediatrician says. Diabete ...
Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...
People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as the companies are nearing to strike U.S. pricing deals for ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.
Shares of Indian generic drugmaker Dr Reddy's Laboratories declined more than 5% on Thursday, after the firm received a non-compliance notice for its semaglutide injection in Canada, which analysts ...
America’s obesity rate is on the decline, a new Gallup poll published Tuesday shows, falling nearly three percent as the use ...
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results